In the 20th-century statistics wars, Bayesians were underdogs. Now their methods may help speed treatments to market.

In today's ACT Brief, we explore how Bayesian methods are reshaping FDA interactions and trial design, quality tolerance limits are becoming operational guardrails in risk-based quality management, ...

Longitudinal data analysis is an essential statistical approach for studying phenomena observed repeatedly over time, allowing researchers to explore both within-subject and between-subject variations ...

Ideally, specific treatment for a cancer patient is decided by a multidisciplinary tumor board, integrating prior clinical experience, published data, and patient-specific factors to develop a ...

Extended educational sessions that offer attendees the opportunity to learn research methods and techniques from prominent psychological scientists.

We review Bayesian and Bayesian decision theoretic approaches to subgroup analysis and applications to subgroup-based adaptive clinical trial designs. Subgroup analysis refers to inference about ...